Results 11 to 20 of about 92,456,624 (252)

No End to Enderby

open access: yes, 2020
The publication to accompany the No End to Enderby films and exhibition by Graham Eatough and Stephen Sutcliffe.
Eatough, Graham, Sutcliffe, Stephen
core   +6 more sources

End-to-end delay.

open access: yes, 2022
End-to-end delay.
Shayesteh Tabatabaei (12280016)
core   +1 more source

End-to-end process flowchart.

open access: yes, 2022
End-to-end process flowchart.
Christopher W. Rowe (12161065)   +3 more
core   +1 more source

Front End to Back End- Compiler Design

open access: yes, 2022
: This research article explains how source code is assessed at the Front End and Back End of the compiler and which sections source code must pass and parse in order to generate target code.
Ms. Chandrani Borah   +2 more
core   +1 more source

End-to-End Delay (ms).

open access: yes, 2017
End-to-End Delay (ms).
Mohamed Othman (1608709)   +3 more
core   +1 more source

End-to-end delay vs time.

open access: yes, 2019
End-to-end delay vs time.
Mohd Amiruddin Abd Rahman (6990044)   +4 more
core   +1 more source

End-to-end coreference resolution for Basque.

open access: yes, 2019
End-to-end coreference resolution for Basque.
Xabier Arregi (7378223)   +3 more
core   +1 more source

End-to-End Speech Recognition on Conversations

open access: yes, 2020
Processing of conversations is a core technique in conversational AI. However, current speech recognition solutions, even the state-of-the-art systems, model a single, isolated utterance, not an entire conversation.
Suyoun Kim (4946740)
core   +1 more source

End-to-end delay of information dissemination with the TLILS with 10 m/s speed.

open access: yes, 2021
End-to-end delay of information dissemination with the TLILS with 10 m/s speed.
Sara Elhishi (11725318)   +2 more
core   +1 more source

Efecto negativo del bloqueo del sistema renina-angiotensina sobre la progresión de la enfermedad renal crónica avanzada: ¿una cuestión de ajuste de dosis?

open access: yesNefrología, 2020
Resumen: Introducción: El efecto renoprotector de los fármacos inhibidores del sistema renina-angiotensina (ISRA) ha sido cuestionado en la enfermedad renal crónica (ERC) avanzada.
Fernando Caravaca-Fontán   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy